MAPT and Alzheimer disease: These results support [18F] JNJ-64326067 as a novel isoquinoline PET tracer for the detection and quantitation of tau aggregates in Alzheimer’s disease research, joining the armamentarium of imaging biomarkers for detection of tau pathology.